rosiglitazone has been researched along with acetyl coenzyme a in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ahmad, N; Gaspari, M; Goel, S; Gupta, G; Jain, SC; Kohli, E; Kumari, R; Olsen, CE; Pal, G; Parmar, VS; Prasad, AK; Raj, HG; Tyagi, YK; van der Greef, J; Watterson, AC | 1 |
Cheng, L; Han, X; Shi, Y | 1 |
Dai, Y; Hu, Y; Miao, Y; Wei, Z; Xue, X; Yang, L; Zeng, X; Zhang, C | 1 |
3 other study(ies) available for rosiglitazone and acetyl coenzyme a
Article | Year |
---|---|
Establishment of the enzymatic protein acetylation independent of acetyl CoA: recombinant glutathione S-transferase 3-3 is acetylated by a novel membrane-bound transacetylase using 7,8-diacetoxy-4-methyl coumarin as the acetyl donor.
Topics: Acetyl Coenzyme A; Acetylation; Acetylesterase; Coumarins; Glutathione Transferase; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2002 |
A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Acetyl Coenzyme A; Animals; Chlorocebus aethiops; Cloning, Molecular; COS Cells; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Models, Animal; Hypoglycemic Agents; Lysophosphatidylcholines; Male; Mice; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transfection | 2009 |
The activation of PPARγ enhances Treg responses through up-regulating CD36/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of TβRII/IL-2Rα.
Topics: Acetyl Coenzyme A; CD36 Antigens; Forkhead Transcription Factors; Interleukin-2 Receptor alpha Subunit; Polysaccharides; PPAR gamma; Rosiglitazone; T-Lymphocytes, Regulatory; Uridine Diphosphate | 2022 |